The effect of premedication on arterial blood gas tensions was studied in thirty adult surgical patients with valvular disease. They were divided into three groups, each group having a different premedication regimen. Blood gas tensions were compared in these patients when awake on the night before surgery, asleep, after premedication and just prior to induction of anaesthesia. Samples were taken while the patient breathed air and each patient acted as his/her own control. The patients were randomised into one of three premedication regimens: 1. intramuscular lorazepam, 2. intramuscular morphine and hyoscine (scopolamine) and 3. orallorazepam plus intramuscular morphine and hyoscine. There was a statistically significant though not clinically significant rise in PaC02 and fall in pH following premedication with lorazepam, morphine and hyoscine. There was also a significant fall in Pa02 associated with morphine and hyoscine premedication which was greater than that which occurred with unsedated sleep. Patients who are to undergo cardiac valvular surgery should receive supplementary oxygen following premedication and during transfer to the operating room.
with cardiac valvular disease. Blood gases were measured in patients awake and asleep the night before operation and before and after premedication.
METHODS AND MATERIALS
Thirty ASA grade 11, III and IV Chinese adult cardiac patients were studied at the Grantham Cardiothoracic Hospital in Hong Kong. Informed consent was obtained in each case and the study was approved by the Hospital Ethics Committee. Patients were assigned to one of three groups by use of a random number table:
Group 1, lorazepam 50 microgramlkg intramuscularly 1.5 hours preoperatively at 0700 hours; Group 2, morphine 200 microgramlkg and hyoscine 8 microgramlkg (maximum dose 0.4 mg), intra muscularly 1.5 hours preoperatively at 0700 hours; Table 1 . No sedation was given preoperatively other than that prescribed in the above protocol.
The evening before operation a 20-gauge arterial cannula was inserted percutaneously into the left radial artery, after local infiltration of the skin with 2% lignocaine. Patients were observed overnight in either the intensive or coronary care units.
Arterial blood samples were drawn from the cannula two hours after the arterial line was inserted with the patient awake and resting. A second sample was taken at 0300 hours with the patient undisturbed and asleep. A third sample was taken in the ward one hour after the intramuscular premedication at 0800 hours, immediately before transfer to the operating theatre. The fourth sample was taken when the patient was placed on the operating table before the induction of anaesthesia at 0830 hours. Samples were drawn anaerobically in heparinised syringes, transported to the laboratory in ice, and analysed in duplicate within fifteen minutes by the same technician on two automatic instruments (Coming Model 178) calibrated immediately prior to analysis. Within the range of blood gas analysis performed during this study, the manufacturer's stated degree of error inherent in this machine was pH ± 0.002 units, PaC02 ± 0.5 mmHg and the Pa02 ± 1.0 mmHg.
On arrival in the operating room, a subjective assessment of the effect of the premedication was made by the attending anaesthetist. The patients were grouped into four categories: 1. agitated; 2. awake, apparently anxiety free; 3. drowsy; 4. asleep but responsive to verbal command.
The type of surgery performed on the patients in this study is given in Table 2 . Patients receiving nitroglycerine as skin paste, sublingually or intravenously, were excluded from the study. 5 The results are presented both as one group of thirty patients, and in three separate premedication groups of ten patients for the four data collection times. The results were statistically analysed using either a paired or unpaired Hest with Bonferroni correction.
RESULTS
Between the three premedicant groups there was no statistically significant difference as regards age, weight, height, mean pulmonary artery pressure, mean left ventricular enddiastolic pressure, mean left atrial pressure and vital capacity expressed as a percentage of a predicted normal value ( Table 1 ). The sex distributions of Groups 1 and 2 were similar: however, Group 3 consisted of nine females and one male. The cardiac chamber pressures, pulmonary artery pressure and respiratory function tests were measured at cardiac catheterisation one month prior to surgery. The subjective assessment of the effect of the three premedication regimens on anxiety and state of consciousness is presented in Table 3 . Most patients were asleep but responded when their name was called by opening their eyes. Patients who were assessed as drowsy spontaneously opened their eyes when transfered to the operating table.
Patients premedicated with both the anxiolytic lorazepam plus the morphine and hyoscine combination appeared more somnolent on arrival in the operating room. alone appeared more aware of their surroundings.
Premedicant group data at the sample times:
( Table 4 ).
Neither the Pa02 or the base excess showed statistical difference between the premedicant groups at any of the four sample times. The pH was lower for Group 3 patients (mean pH 7.40) compared with Group 2 patients (mean pH 7.46) after premedication (P < 0.05).
Likewise the PaC02 was elevated when comparing the same two premedicant groups (Group 3 mean PaC02 40.4 mmHg, Group 2 mean P aC02 34.7 mmHg) after premedication (P < 0.02). However the mean values for pH and PaC02 were within the normal clinically accepted range.
Pooled premedicant data at the sample times: (Figure 1).
The P a o 2 values in both the premedicated (mean P a o 2 84.1 mmHg) and the preoperative state (mean P a o 2 80.5 mmHg) were significantly lower than in the awake state (mean Pa02 89.7 mmHg P< 0.02, and P < 0.001 respectively). In addition, the preanaesthetic induction Pa02 (mean Pa02 80.5 mmHg) was significantly lower than the asleep value (mean Pa02 86.5 mmHg,
Considering the data of the thirty patients as a group irrespective of the premedication regimen, there was found to be no statistically significant difference between the base excess or pH values at any of the four times of sampling. There was a significant rise in sleeping PaC02 (mean PaC02 39.4 mmHg) compared with awake values (mean PaC02 36.6 mmHg, P<O.Ol), but this was not reflected in the pH data.
Premedicant group data:
Group 1 (lorazepam alone): there was no statistically significant change in Pa02 or base excess at any of the sampling times during the study. The PaC02 however rose when the patient was asleep (mean PaC02 40.9 mmHg) compared with the awake state (mean PaC02 37.0 mmHg, P < 0.02) and there was a significant rise in PaC02 when the asleep (mean PaC02 40.9 mmHg) and postpremedication states were compared (mean (II).ean pH 7.40) and pre-anaesthetic induction samples (mean pH 7.44, P< 0.01). Group 2 (morphine and hyoscine): Analysis of results revealed that the pre-anaesthetic Pa02 (mean Pa02 73.5 mmHg) was significantly lower than that for both the awake (mean Pa02 87.0 mmHg) and asleep states (mean Pa02 84.5 mmHg, P<O.Ol). Similarly the pre-anaesthetic Pa02 (mean Pa02 73.5 mmHg) was significantly lower than the post premedication value (mean Pa02 85.8 mmHg, P < 0.01) ( Figure 2 ). Group 3 (lorazepam, morphine and hyoscine): These patients showed a significant fall in Pa02 between the awake (mean Pa02 93.4 mmHg) and both the post-premedication (mean P a 0 2 81.4 mmHg, P< 0.001), and the pre-anaesthetic induction states (mean Pa02 82.7 mmHg, P < 0.01). In addition, there was a fall in pH in the awake (mean pH 7.43) compared with the asleep state (mean pH 7.41, P< 0.05) and the awake (mean pH 7.43) compared with the post-premedication state (mean pH 7.41, P< 0.01). However no statistical difference was demonstrated as regards P aC02 or base excess in any of the four data groups for the Group 3 premedication regimen. 
DISCUSSION
The aim of this study was to determine whether premedication with lorazepam alone, morphine plus hyoscine or a combination of all three drugs caused a greater change in arterial blood gases than that which occurred during normal sleep. Both the morphine and hyoscine and the lorazepam, morphine and hyoscine groups demonstrated a significant fall in Pa02 just prior to the induction of anaesthesia. The decline in P a02 was seen earlier in the lorazepam, morphine and hyoscine group, perhaps because the lorazepam was given earlier, though the magnitude of the drop was no greater than the morphine and hyoscine group.
There are several anomalies apparent in the data. There is no statistical difference in P a 0 2 between any of the three premedicant groups, at any of the sampling times. A conclusion drawn from these data is that none of these premedicant regimens has an advantage in regard to Pa02. However, other factors such as cardiac disease related ventilation/perfusion mismatching may hide a real difference which is simply not demonstrated.
When considering the paired data (all premedicant regimens as one group, (n = 30), ' . I 1 Aft.r a.'or. there is a fall in Pa02 at the sample time immediately before anaesthetic induction, which is significantly greater than that which occurs with natural sleep. Our results confirm the work of other investigators2-4,6.7 that premedication reduces P a02, both one hour post-premedication and immediately preinduction, when compared with the awake unpremedicated values. However, the reduced Pa02 seen immediately before induction of anaesthesia was significantly more than that occurs with natural sleep, though the reduced Pa02 postpremedication was not statistically different from the asleep values. The reason for this is unclear, but possible explanations include the suggestion that the transfer of the patient to the operating suite may have caused a sudden increase in anxiety, therefore increasing oxygen consumption; movement of the patient caused a worsening of venous admixture; and that the premedication had longer to produce an effect. It would appear from these results that supplementary oxygen should be administered to the patient to prevent hypoxia during transport to the operating suite and immediately before induction.
The morphine and hyoscine group of patients showed a marked reduction in Pa02 just before anaesthetic induction. This was significantly more pronounced than that seen in the lorazepam, morphine and hyoscine group. The lorazepam premedicated patients showed no within-group statistical difference when comparing any of the Pa02 sampling times. It would appear from these results that patients given morphine and hyoscine have significantly reduced Pa02 while those given lorazepam suffer minimal change in Pa02. Though statistical analysis of the results in Table 4 does not reveal a difference between premedicant regimens as regards Pa02, using paired data shows that lorazepam alone has the least effect on Pa02.
The combination of lorazepam, morphine and hyoscine caused a significant fall in P a02 which occurred post-premedication, but was of no greater magnitude at the pre-anaesthetic induction sampling time. This may be a reflection of the different pharmacodynamic properties of these drug combinations.
Lorazepam administered orally produces peak plasma levels in two to four hours, plasma levels being proportional to dose and sedative effects being proportional to plasma levels. 8 In human volunteers, the peak analgesic effect of morphine given intramuscularly occurs within 30 to 60 minutes, while the peak respiratory depressant effect occurs within 30 minutes. 9 This may not be true in patients with an impaired circulation.
Neither the sedative nor the respiratory depressant effects correlate with the drug's peak depressant effect on Pa02. The lorazepam, morphine and hyoscine group was also given lorazepam the evening before operation. Lorazepam has a biological halflife often to twelve hours, yet no difference in Pa02 or PaC02 was shown when the awake and asleep samples were compared. Therefore, although lorazepam by itself had little effect on P a02, when added to morphine and hyoscine, a reduction in P a02 occurred sooner (that is, at the post-premedication sample time) than in the morphine and hyoscine group. There is no evidence that lorazepam directly influences muscle blood flow.
The patients chosen for the study were ASA grades 11, III and IV with severely abnormal pulmonary haemodynamics as evidenced by the elevated mean left ventricular enddiastolic pressures, pulmonary artery pressures and left atrial pressures. Restrictive lung function was demonstrable in all patients with grossly enlarged hearts.
The patients were 'heavily' premedicated as a routine to promote a minimal stress anaesthetic IO and 96% of the patients were asleep or appeared anxiety-free, when assessed pre-induction by the anaesthetist. There was no significant difference in the mean ages of the three premedicant groups, although there was a wide range (20 to 67 years). The more elderly showed severe reduction in Pa02 with premedication, but none of these patients had a Pao2less than 60 mmHg at any of the sampling times. The lorazepam, morphine and hyoscine group contained nine females and one male patient. This skewed distribution may perhaps have biased the results, as work by Block et al. demonstrates a lesser degree of oxygen desaturation in normal women compared with men when asleep.!! Therefore the reduction in Pa02 shown with the lorazepam, morphine and hyoscine group may have been less than that expected with a more equal sex distribution.
Interestingly, in this study, each of the three premedication regimens resulted in less rise in PaC02 than was caused by natural sleep. There was a statistically significant increase in PaC02 and corresponding fall in pH when the lorazepam, morphine and hyoscine group was compared with the morphine and hyoscine group at the time of the post-premedication sample. This difference was clinically not important and none of the samples measured a PaC02 greater than 47 mmHg. Lorazepam, morphine and hyoscine caused a greater depression in respiration than morphine and hyoscine though in both cases this was less than occurred with normal sleep.
The decrease in Pa02 cannot be explained on the basis of a rise in PaC02 alone,4 and in this series the PaC02 post-medication was not significantly different from awake values. The fall in Pa02 post-premedication has been related to an alteration in lung mechanics!2 and to the development of venous admixture. 2 ,!3 Because of the underlying disease the selection of cases for this study was biased from inception, and the patients may have had pulmonary diffusion, perfusion and ventilation abnormalities making comparisons with other studies difficult. There are insufficient data to predict the effect of narcotics on lung function in these patients with valvular heart disease and further investigation of their ventilation and perfusion abnormalities is required before firm conclusions can be drawn. In addition this study suffers the limitations of intermittent rather than continuous sampling of the Pa02 which could be solved by pulse oximetry and continuous analysis of the results.
CONCLUSIONS
This study has shown that significant deoxygenation may occur after morphine and hyoscine premedication in patients with valvular heart disease. It is suggested that these patients should be given supplementary oxygen while being transferred to the Anaesthesia and Intensive Care. Vol. 18, No. I. February, 1990 operating suite. The depression of ventilation with premedication is no greater than that which occurs with natural sleep. Of the premedicants used in this study, lorazepam alone is the premedicant of choice if the degree of deoxygenation following premedication is to be limited.
